Beschreibung
Diltiazem combined with metoprolol increases the risk of bradycardia and AV block through additive negative chronotropic and dromotropic effects.
Mechanismus
Diltiazem inhibits L-type calcium channels in SA and AV nodes, slowing conduction; metoprolol's beta-1 blockade also slows AV nodal conduction. The effects are additive.
Klinische Bedeutung
Symptomatic bradycardia and AV block have been documented; less severe than verapamil + beta-blocker but still clinically significant.
Maßnahmen
Monitor heart rate and ECG; start at low doses; avoid combination in patients with pre-existing conduction system disease or sinus node dysfunction.
Medizinischer Haftungsausschluss
This content is for educational and informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making medication decisions.